Neurological Disease
14
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions
Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ
Technological Devices and Home Automation System in Neurological Rehabilitation
Manipulating and Optimizing Brain Rhythms for Enhancement of Sleep
Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes
Positioning in Wheelchair Bound Patients
Development, Reliability and Validity of the Telerehabilitation Satisfaction Questionnaire- TrSQ
Investigational Biomarkers for Neurological Immune-related Adverse Events
Eye Tracking Technology in the Diagnosis of Neurological Patients
Outcome Measures Study on an Adult Myoelectric Elbow-Wrist-Hand Orthosis
Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit
Procedures, Complications and Follow-up of Tracheostomy in Intensive Care Units.
Tracheostomy in ICU With a Double Lumen Endotracheal Tube
Cerebral, Meningeal Biopsy by Flexible Endoscopy in Patients Without Neurological Diagnosis